title: PSC833: initial clinical results in refractory ovarian cancer patients.
authors.affiliation: Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA.
authors.forename: A
authors.initials: A
authors.lastname: Fields
authors.forename: H
authors.initials: H
authors.lastname: Hochster
authors.forename: C
authors.initials: C
authors.lastname: Runowicz
authors.forename: J
authors.initials: J
authors.lastname: Speyer
authors.forename: G
authors.initials: G
authors.lastname: Goldberg
authors.forename: C
authors.initials: C
authors.lastname: Cohen
authors.forename: P
authors.initials: P
authors.lastname: Dottino
authors.forename: S
authors.initials: S
authors.lastname: Wadler
authors.forename: G
authors.initials: G
authors.lastname: Berk
authors.forename: H
authors.initials: H
authors.lastname: Gretz
authors.forename: J
authors.initials: J
authors.lastname: Mandeli
authors.forename: J
authors.initials: J
authors.lastname: Holland
authors.forename: L
authors.initials: L
authors.lastname: Letvak
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000494:pharmacology / Q000627:therapeutic use; D011446:Prospective Studies; D016879:Salvage Therapy; D016896:Treatment Outcome